neuroClues

Eye-tracking technology for early disease detection.

Edited:

📋 Overview of neuroClues

Founding Year

2020

Estimated Funding

$0000

Size

$0000

Locations

Wisconsin

Primary Industry

Health Diagnostics

📙 About neuroClues

NeuroClues, developed by P3Lab, leverages advanced eye-tracking technology to offer a non-invasive method for detecting and monitoring neurological diseases long before symptoms appear. It provides clinicians with real-time, objective biomarkers that improve early diagnosis and track disease progression with high precision. It integrates these insights to support more accurate assessments and better patient management.

💰 Recent Investors of neuroClues

European Innovation Council Fund, Fiona Monceau, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.